Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 4OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, Mantle-Cell 26Lymphoma, Non-Hodgkin 22Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma, B-Cell 14Lymphoma, Follicular 13Recurrence 12Waldenstrom Macroglobulinemia 9Neoplasms 8Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphoid 6Leukemia, B-Cell 6Bronchiolitis Obliterans Syndrome 6Multiple Myeloma 5Graft vs Host Disease 4Lymphoproliferative Disorders 3Lymphatic Diseases 3Leukemia, Myeloid, Acute 3Leukemia 3Immunoproliferative Disorders 3Immune System Diseases 3Hematologic Neoplasms 3Hematologic Diseases 2Burkitt Lymphoma 2Breast Neoplasms 2Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Myeloproliferative Disorders 1

Interventions

tisagenlecleucel 8Cyclophosphamide 7fludarabine 5blinatumomab 5aflibercept 4ibrutinib 2epratuzumab 2Vincristine 2Radioimmunodetection 2Methotrexate 2MLN 8237 2Inotuzumab Ozogamicin 2Dexamethasone 2tocilizumab 1tafasitamab 1siltuximab 1sepantronium 1ruxolitinib 1relatlimab 1pembrolizumab 1pegaspargase 1ontuxizumab 1obinutuzumab 1loncastuximab tesirine 1forodesine 1fludarabine phosphate 1fiu protein, E coli 1exatecan 1brexucabtagene autoleucel 1asparaginase erwinia chrysanthemi recombinant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Burkitt Lymphoma × ibrutinib × Clear all
NCT01109069 2020-05-27

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

Pharmacyclics LLC.

Phase 2 Completed
199 enrolled 14 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT00849654 2013-05-22

PCYC-04753

Pharmacyclics LLC.

Phase 1 Completed
66 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoid, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡